Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Generic drugs
Pharma
Teva's patent and communications strategies in Turkey face probe
But Teva's foot in both realms is now being highlighted as it faces scrutiny over whether it stymied generics to its innovative drugs in Turkey.
Fraiser Kansteiner
,
Zoey Becker
Aug 26, 2026 8:15am
Appeals court sides partially with Teva in IRA pricing lawsuit
Aug 19, 2026 7:45am
Sandoz inks dual settlements to resolve most US antitrust claims
Aug 3, 2026 10:18am
Fierce Biotech
How India can build on its budding innovative R&D moment: report
Jul 23, 2026 5:00am
Trump floats countdown to 200% tariff rate on imported generics
Jul 22, 2026 11:00am
Alembic site hit with warning letter on patient consent concerns
Jul 21, 2026 11:40am
